葛兰素史克(GSK)

搜索文档
新药品关税“雷声大雨点小”? 瑞银:主要药企已在美投资数百亿美元,可获完全豁免
智通财经网· 2025-09-27 00:13
特朗普周四晚间宣布对进口药品征收100%关税后,瑞银等投行纷纷告诉客户,这一政策的实际影响或 将微乎其微。分析师指出,由于大型制药公司已在美国投资数百亿美元建设生产设施,大多数企业可获 得关税豁免。 据央视新闻报道,当地时间9月25日,美国总统特朗普在其社交媒体"真实社交"宣布,自10月1日起,美 国将对多类进口产品实施新一轮高额关税,其中对专利及品牌药品加征100%关税。 根据特朗普在社交媒体上的表态,对"任何品牌或专利药品"的100%关税将从10月1日起生效,但正在美 国建设制药生产厂的公司可获豁免。这一豁免条款被定义为"破土动工"或"在建中",只要开始施工就无 需缴纳关税。 周五亚洲股市因关税消息走低,亚洲制药股出现下滑。但欧洲大型制药股在特朗普隔夜宣布药品进口关 税后表现相对稳定。 所有大型制药公司都在美国有业务存在,几乎所有公司都宣布了未来几年的大规模投资计划。 Mizuho Securities医疗保健专家Jared Holz在报告中称,声明很直接,但其影响可能介于模糊和微不足道 之间。所有主要参与者都在美国有一些生产业务,几乎所有公司都宣布了直接与本地制造相关的增加投 资。 根据生物技术创新组织 ...
新药品关税“雷声大雨点小”?瑞银:主要药企已在美投资数百亿美元,可获完全豁免
华尔街见闻· 2025-09-26 14:27
特朗普周四晚间宣布对进口药品征收100%关税后,瑞银等投行纷纷告诉客户,这一政策的实际影响或 将微乎其微。分析师指出,由于大型制药公司已在美国投资数百亿美元建设生产设施,大多数企业可获 得关税豁免。 据央视新闻报道,当地时间9月25日,美国总统特朗普在其社交媒体"真实社交"宣布,自10月1日起,美 国将对多类进口产品实施新一轮高额关税,其中对专利及品牌药品加征100%关税。 根据特朗普在社交媒体上的表态,对"任何品牌或专利药品"的100%关税将从10月1日起生效,但正在美 国建设制药生产厂的公司可获豁免。这一豁免条款被定义为"破土动工"或"在建中",只要开始施工就无 需缴纳关税。 周五亚洲股市因关税消息走低,亚洲制药股出现下滑。但欧洲大型制药股在特朗普隔夜宣布药品进口关 税后表现相对稳定。 市场普遍认为,鉴于主要药企已有大量美国生产布局,新关税政策的实际冲击有限。分析师预计,这一 政策更多具有象征意义,旨在推动制药业回流美国,而非真正打击进口药品贸易。据彭博经济学家分 析,受此举影响最大的国家是新加坡和瑞士。英国也有一些重要的对美制药出口——其与美国的贸易协 定提到,如果出现新的232条款关税,将考虑特殊税率 ...
集体大跌!特朗普宣布:100%关税!
券商中国· 2025-09-26 01:06
特朗普再挥"关税大棒"。 当地时间9月25日,美国总统特朗普宣布,自10月1日起,美国将对多类进口产品实施新一轮高额关税,其中对 任何品牌或专利的医药产品征收100%的关税;对厨房橱柜、浴室洗手台及相关建材征收50%关税;对进口家 具征收30%关税。此外,自10月1日起将对所有进口重型卡车加征25%关税。 受此影响,日韩、澳大利亚医药股全线走低,截至北京时间26日08:40,澳大利亚CSL大跌超4%,Telix Pharma、Neuren Pharmaceuticals大跌超3%;日本住友制药大跌超4%、第一三共大跌超3%、武田药品、 Astellas Pharma跌超1%;韩国Samsung Biologics大跌超3%,SK Biopharmaceuticals、Yuhan跌超2%。 有分析人士警告称,针对医药产品的高额关税,可能会推高成本并扰乱药品供应链,从而使美国患者面临风 险。另外,在美国通胀本已高企的背景下,新的关税措施无疑将加剧物价上涨压力,并可能拖累经济增长,让 本已在适应此前关税环境的企业面临新一轮不确定性。 特朗普宣布 据央视新闻9月26日报道,当地时间9月25日,美国总统特朗普在其社交媒 ...
GSK plc (GSK) plc Presents at Bank of America Global Healthcare Conference 2025 Transcript
Seeking Alpha· 2025-09-24 13:43
PresentationSachin Jain here from the European team, Bank of America. It's my pleasure to be hosting Glaxo. We have Julie Brown, CFO, Tony Wood, Head of R&D; and then IR folks, Constantin and Mick in the front. We have about 40 minutes, and I'll aim to split it roughly half-half between Julie and Tony, but perhaps if you wanted to make some introductory comments and we'll get into questions.Julie BrownCFO & Executive Director Yes, sure. Good morning, everybody. Good to see everybody. So obviously, in GSK, w ...
Buffett's September DiviDogs Tag 6 'Safer' Berkshire Watch Dogs
Seeking Alpha· 2025-09-24 13:43
Get The Entire Buffett-Berkshire Hathaway Dividend Dog StoryClick here to subscribe to The Dividend Dogcatcher. Get more information, the follow-up to this article, and a free two week trial.Catch A Dog On Facebook at 10AM or so ET before every NYSE trade day on Facebook/Dividend Dog Catcher, A Fredrik Arnold live video highlights a portfolio candidate in the Underdog Daily Dividend Show!Root for the Underdog. Comment below on all your favorite, least favorite and curiosity stock tickers to make them eligib ...
Chinese giant Xiaomi challenges Samsung with new smartphones and appliances
CNBC· 2025-09-24 13:43
产品发布 - 小米在慕尼黑国际发布会上推出Xiaomi 15T系列智能手机 包括Xiaomi 15T和Xiaomi 15T Pro两款机型[1] - 新机型定价分别为649欧元(约766美元)和799欧元 延续高性价比策略 配备三摄系统、6.83英寸大屏和大容量电池[2] - 15T系列定位为"经济型旗舰" 以高端功能但比顶级高端设备低半档的价格为卖点[3] 市场竞争 - 直接对标三星中端A系列和高端S系列手机 三星S25起售价799欧元 S25 Ultra德国起售价1249欧元[2][3] - 公司在欧洲市场份额排名第三 仅次于三星和苹果 通过高端和中端产品组合对两大巨头形成强劲挑战[4] - 分析师认为这是公司高端化战略的重要步骤 旨在吸引预算敏感但注重规格的高端设备买家[5] 战略布局 - 公司持续扩大地理覆盖和产品范围 从洗衣机到电动汽车等多领域拓展[3] - 同步宣布Mijia品牌家电全球上市 包括冰箱、洗衣机和空调 复制三星跨品类全球销售模式[5][6] - 凭借高性价比优质产品的运营模式 对进入领域的任何竞争对手构成压力[6] 产品线规划 - 今年早些时候已在国际市场推出更昂贵的小米15手机[4] - 在中国市场正筹备发布17系列旗舰设备[4]
Pi Health to Collaborate with GSK to Enhance Clinical Research Services
Businesswire· 2025-09-24 11:45
Sep 24, 2025 7:45 AM Eastern Daylight Time Pi Health to Collaborate with GSK to Enhance Clinical Research Services Share Pi Health will leverage its Front-end Interoperable Capture System (FICS) platform — integrated with an international network of clinical trial sites across the globe — for the clinical trial. FICS is an end-to-end clinical trial software platform with artificial intelligence capabilities that enriches current systems by using a unified solution that connects sites and sponsors to acceler ...
GSK (NYSE:GSK) 2025 Conference Transcript
2025-09-24 09:02
GSK (NYSE:GSK) 2025 Conference September 24, 2025 04:00 AM ET Company ParticipantsTony Wood - Head of R&DJulie Brown - CFOConference Call ParticipantsNone - AnalystNone - AnalystNoneJay here from the European team at Bank of America. It's my pleasure to be hosting Glaxo. We have Julie Brown, CFO, Tony Wood, Head of R&D, and then IR folks, Constantin and Mick in the front. We have about 40 minutes, and I'll aim to split it roughly half-half between Julie and Tony. Perhaps each of you wanted to make some intr ...
GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism
Youtube· 2025-09-22 22:20
response from the maker of wooin, one of the drugs President Trump and HHS Secretary RFK Jr. . were talking about at that event. Angelica, [Music] hey Mel.Well, the FDA is saying that they are going to move forward with trying to approve Lucavorin for the treatment of some of the symptoms of autism. Now, of course, GSK made the brandame version of that drug, but they pulled that off the market in 1997 and now it's really all generics. and a GSK spokesperson telling me that GSK has no intention to market tha ...
Trump claims Tylenol use during pregnancy linked to autism, suggests Leucovorin as treatment
MINT· 2025-09-22 21:15
US President Donald Trump on Monday (September 22) suggested a connection between the use of over-the-counter pain medication Tylenol during pregnancy and the development of autism, a claim that many medical experts dispute.“Taking Tylenol is not good. I'll say it. Not good,” Trump said. "For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary."He added, “You shouldn't give the child a Tylenol every time he gets a shot.”The President also ment ...